Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers : A phase I study in Japanese patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-04-10
著者
-
Minami Hironobu
Division Of Oncology/hematology National Cancer Center Hospital East
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Minami Hironobu
名古屋第一赤十字病院
-
Minami Hironobu
National Cancer Center Hospital East
-
Minami H
Department Of Hematology Fujita Health University School Of Medicine
-
Higashihara Masaaki
北里大学 医学部第4内科(血液内科)
-
Mukai Hirofumi
国立がんセンター東病院 化学療法科血液
-
Itoh Kuniaki
National Cancer Center Hospital East Oncology/hematology
-
Mukai Hirofumi
National Cancer Center Hospital East Oncology/hematology
-
Nakajima Hikaru
National Cancer Center Hospital East Oncology/hematology
-
MUKOHARA Toru
National Cancer Center Hospital East, Oncology/Hematology
-
NAGAI Shunji
National Cancer Center Hospital East, Oncology/Hematology
-
UMEYAMA Yoshiko
Pfizer Japan Inc.
-
HASHIMOTO Junichi
Pfizer Japan Inc.
-
Minami Hironobu
The Division Of Oncology/hematology National Cancer Center Hospital East
-
Minami Hironobu
Oncology/hematology National Cancer Center Hospital East
-
Minami Hironobu
Department Of Hematology Fujita Health University School Of Medicine
-
Nagai Shunji
National Cancer Center Hospital East
-
Nagai Shunji
National Cancer Center Hospital East Oncology/hematology
-
Mukohara Toru
National Cancer Center Hospital East Oncology/hematology
-
Mitsuya Hiroaki
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
Minami Hironobu
National Cancer Center Hospital East Oncology/hematology
-
Mukai Hirofumi
Division Of Oncology And Hematology National Cancer Center Hospital East
関連論文
- Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Twelve Novel Single Nucleotide Polymorphisms in the CES2 Gene Encoding Human Carboxylesterase 2 (hCE-2)
- Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
- 日本人におけるヒトSLC29A1の新規遺伝子多型の同定
- Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
- Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
- Genetic Polymorphisms of UGT1A6 in a Japanese Population
- Genetic Variations of the AHR Gene Encoding Aryl Hydrocarbon Receptor in a Japanese Population
- Three Novel Single Nucleotide Polymorphisms in UGT1A9
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Novel Genetic Polymorphisms in the NR3C1 (Glucocorticoid receptor) Gene in a Japanese Population
- Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
- Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
- Three novel single nucleotide polymorphisms in UGT1A10
- Constitutive Activity of Nuclear Transcription Factor kB is Observed in Follicular Lymphoma
- Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases
- Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
- Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
- Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
- Extragonadal germ cell tumors in Japan
- Treatable Subsets in Cancer of Unknown Primary Origin
- Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
- Association of SLCO1B3 Polymorphism with Intracellular Accumulation of Imatinib in Leukocytes in Patients with Chronic Myeloid Leukemia
- P-Glycoprotein Mediates Efflux Transport of Darunavir in Human Intestinal Caco-2 and ABCB1 Gene-Transfected Renal LLC-PK1 Cell Lines
- Population pharmacokinetic and pharmacodynamic analysis for time courses of docetaxel-induced neutropenia in Japanese cancer patients
- Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
- Spontaneous Remission of Secondary Hyperparathyroidism due to Hemorrhagic Infarction in a Uremic Patient Undergoing Maintenance Hemodialysis
- Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers : A phase I study in Japanese patients
- Treatment strategy for HER2-positive breast cancer
- Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)
- Cooperative induction of histidine decarboxylase (HDC) and histamine H_2 receptor in the infiltrating cells participate in the regulation of inflammation induced by unilateral ureteral obstruction (UUO)
- MPO-ANCA-Positive Slowly Progressive Glomerulonephritis with Focal Tuft Necrosis and Crescents
- A study regarding the relationship between the complexity of heart rate variability and hemodialysis-induced hypotension
- Staphylococcal scalded skin syndrome in a uremic patient undergoing maintenance hemodialysis
- P-39 2'-DEXY-4'-C-ETHYNYL-2-FLUOROADENOSINE, A NRTI THAT COULD BE AN IDEAL DRUG FOR BOTH HIV-AND HBV-INFECTIONS
- Synthesis of the L-Enantiomer of 4'-C-Ethynyl-2'-deoxycytidine(Organic Chemistry)
- Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drug
- Micafungin-induced immune hemolysis attacks
- Long-term Efficacy of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Therapy of Aplastic Anemia
- Two Cases Showing Clonal Progression With Full Evolution From Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria Syndrome to Myelodysplastic Syndromes and Leukemia
- Establishment and Characterization of a Novel Human Chronic Myelogenous Leukemic Cell Line, MT-12
- Successful Management of Malignant Ascites by Intraperitoneal Carboplatin Injection in A Case with Adult T-cell Leukemia/Lymphoma
- Myosin Light Chain Phosphorylation is Correlated with Cold-Induced Changes in Platelet Shape
- An Experimental Renal Disease Induced by the Genetic Immunization of Alpha-2 Macroglobulin Receptor-Associated Protein cDNA
- Molecular Cloning and Sequencing of Myosin Light Chains in Human Megakaryoblastic Leukemia Cells
- Diversity in the Sorting Disorder Induced by the Mutant CIC-5 Chloride Channels Responsible for Dent's Disease
- Oral Melphalan, Dexamethasone, and Thalidomide for the Treatment of Refractory Multiple Myeloma
- Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia
- A Novel Type of Factor XI Deficiency Showing Compound Genetic Abnormalities: A Nonsense Mutation and an Impaired Transcription
- Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population
- Prognostic Factors for Short-term Survival in Patients with Stage IV Non-small Cell Lung Cancer
- Pharmacokinetic Study of Carboplatin Given on a 5-Day Intravenous Schedule
- Therapeutic Drug Monitoring in 21-Day Oral Etoposide Treatment for Lung Cancer
- Therapeutic Drug Monitoring of Etoposide in a 14-Day Infusion for Non-small-cell Lung Cancer
- Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3-Hour Infusion of Paclitaxel
- Hodgkin's Lymphoma and CD30 Signal Transduction
- A novel domain in the CD30 cytoplasmic tail mediates NFkB activation
- Thrombopoietin Stimulates Murine Lineage Negative, Scal-1^+, C-Kit^+, CD34^- Cells: Comparative Study With Stem Cell Factor or Interleukin-3
- Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
- Occult Thymic Carcinoma Presenting as Malignant Cardiac Tamponade
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Chemical Identity of a Rotting Animal-Like Odor Emitted from the Inflorescence of the Titan Arum (Amorphophallus titanum)
- Cellular Myosin Heavy Chain in Human Platelets : Subcloning of the cDNA Encoding Nonmuscle Myosin II Heavy Chain
- The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma
- Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East
- Phase I dose escalation and pharmacokinetic study of oral enzastaurin (LY317615) in advanced solid tumors
- Dimethyl Trisulfide as a Characteristic Odor Associated with Fungating Cancer Wounds
- Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck
- A case of giardiasis expressing severe systemic symptoms and marked hypereosinophilia
- Three Cases of Aggressive Natural Killer Cell Leukemia with a Lethal Hemorrhagic Complication
- Abacavir/Lamivudine versus Tenofovir/Emtricitabine with Atazanavir/Ritonavir for Treatment-naive Japanese Patients with HIV-1 Infection: A Randomized Multicenter Trial
- Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer : a new risk model for success from an analysis of 75 cases